QA: Nanoviricides INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2017_Nanoviricides_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 24,381,643
1 IntangibleAssetsNetIncludingGoodwill 391,467
2 PropertyPlantAndEquipmentNet 11,760,767
3 remainder_Assets 99,541
4 LiabilitiesCurrent 6,744,014
5 LiabilitiesNoncurrent 6,841,190
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,783,413
9 ResearchAndDevelopmentExpense 4,863,873
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,093,643
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 36,633,418
1 Liabilities 13,585,204
2 Expenses 8,647,286
3 Revenues 0
4 StockholdersEquity 23,048,214
5 NetIncome -6,553,643
6 ComprehensiveNetIncome -6,553,643
7 BaseVar 30,479,776
8 EconomicCapitalRatiobeforeLimitedLiability 1.74
9 EconomicCapitalRatio 2.85

Edgar->Model Mapping

Feature Distribution

Change over Time